These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28888001)

  • 1. A targeted nanocarrier based on polyspermine for the effective delivery of methotrexate in nasopharyngeal carcinoma.
    Ji X; Guo H; Tang Q; Ma D; Xue W
    Mater Sci Eng C Mater Biol Appl; 2017 Dec; 81():48-56. PubMed ID: 28888001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Preparation of folate-targeted magnetic nanocomposites loaded with TFPI-2 plasmid and cisplatin and evaluation of its targeting and inhibitory effect on nasopharyngeal carcinoma HNE-1 cells in vitro].
    Liu RZ; Zhang J; Liu T; Fu XY; Zhang LM; Xie MQ
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(25):2023-30. PubMed ID: 27470963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cationic polymeric prodrug with chemotherapeutic self-sensibilization co-delivering MMP-9 shRNA plasmid for a combined therapy to nasopharyngeal carcinoma.
    Liu T; Wu X; Chen S; Wu P; Han H; Zhang H; Li J; Li G; Zhang S
    Drug Deliv; 2019 Dec; 26(1):1280-1291. PubMed ID: 31793355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmented anticancer activity of a targeted, intracellularly activatable, theranostic nanomedicine based on fluorescent and radiolabeled, methotrexate-folic Acid-multiwalled carbon nanotube conjugate.
    Das M; Datir SR; Singh RP; Jain S
    Mol Pharm; 2013 Jul; 10(7):2543-57. PubMed ID: 23683251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendrimeric anticancer prodrugs for targeted delivery of ursolic acid to folate receptor-expressing cancer cells: synthesis and biological evaluation.
    Gao Y; Li Z; Xie X; Wang C; You J; Mo F; Jin B; Chen J; Shao J; Chen H; Jia L
    Eur J Pharm Sci; 2015 Apr; 70():55-63. PubMed ID: 25638419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid-modified methotrexate-conjugated gold nanoparticles as nano-sized trojans for drug delivery to folate receptor-positive cancer cells.
    Yücel O; Şengelen A; Emik S; Önay-Uçar E; Arda N; Gürdağ G
    Nanotechnology; 2020 Aug; 31(35):355101. PubMed ID: 32413875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of FA-targeted magnetic nanocomposites co-loading TFPI-2 plasmid and cis-platinum and its targeted therapy effects on nasopharyngeal carcinoma.
    Liu F; Chen B; Chen W; Chen S; Ma D; Xie M
    Int J Med Sci; 2021; 18(11):2355-2365. PubMed ID: 33967612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of folic acid functionalized bioactive glass for targeted delivery and sustained release of methotrexate.
    Chen J; Chen X; Yang Z; Tan X; Wang J; Chen Y
    J Biomed Mater Res A; 2019 Feb; 107(2):319-329. PubMed ID: 30450695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced toxicity and cellular uptake of methotrexate-conjugated nanoparticles in folate receptor-positive cancer cells by decorating with folic acid-conjugated d-α-tocopheryl polyethylene glycol 1000 succinate.
    Junyaprasert VB; Dhanahiranpruk S; Suksiriworapong J; Sripha K; Moongkarndi P
    Colloids Surf B Biointerfaces; 2015 Dec; 136():383-93. PubMed ID: 26433645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
    Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
    Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells.
    Barar J; Kafil V; Majd MH; Barzegari A; Khani S; Johari-Ahar M; Asgari D; Coukos G; Omidi Y
    J Nanobiotechnology; 2015 Mar; 13():26. PubMed ID: 25880772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted dendrimeric anticancer prodrug: a methotrexate-folic acid-poly(amidoamine) conjugate and a novel, rapid, "one pot" synthetic approach.
    Zhang Y; Thomas TP; Desai A; Zong H; Leroueil PR; Majoros IJ; Baker JR
    Bioconjug Chem; 2010 Mar; 21(3):489-95. PubMed ID: 20128612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyvalent dendrimer-methotrexate as a folate receptor-targeted cancer therapeutic.
    Thomas TP; Huang B; Choi SK; Silpe JE; Kotlyar A; Desai AM; Zong H; Gam J; Joice M; Baker JR
    Mol Pharm; 2012 Sep; 9(9):2669-2676. PubMed ID: 22827500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential usage of the transport systems for folic acid and methotrexate in normal human T-lymphocytes and leukemic cells.
    Biswal BK; Verma RS
    J Biochem; 2009 Nov; 146(5):693-703. PubMed ID: 19692428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arabinogalactan-folic acid-drug conjugate for targeted delivery and target-activated release of anticancer drugs to folate receptor-overexpressing cells.
    Pinhassi RI; Assaraf YG; Farber S; Stark M; Ickowicz D; Drori S; Domb AJ; Livney YD
    Biomacromolecules; 2010 Jan; 11(1):294-303. PubMed ID: 20014825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox-responsive chemosensitive polyspermine delivers ursolic acid targeting to human breast tumor cells: The depletion of intracellular GSH contents arouses chemosensitizing effects.
    Ji X; Tang Q; Pang P; Wu J; Kirk TB; Xu J; Ma D; Xue W
    Colloids Surf B Biointerfaces; 2018 Oct; 170():293-302. PubMed ID: 29936382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-targeted star-shaped cationic copolymer co-delivering docetaxel and MMP-9 siRNA for nasopharyngeal carcinoma therapy.
    Liu T; Wu X; Wang Y; Zhang T; Wu T; Liu F; Wang W; Jiang G; Xie M
    Oncotarget; 2016 Jul; 7(27):42017-42030. PubMed ID: 27259274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting and inhibition of cell growth by an engineered dendritic nanodevice.
    Thomas TP; Majoros IJ; Kotlyar A; Kukowska-Latallo JF; Bielinska A; Myc A; Baker JR
    J Med Chem; 2005 Jun; 48(11):3729-35. PubMed ID: 15916424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionalized Graphene Oxide as a nanocarrier of new Copper (II) complexes for targeted therapy on nasopharyngeal carcinoma.
    Li G; Yang Y; Zhou R; Meng F; Li X
    Eur J Pharm Sci; 2018 Oct; 123():249-259. PubMed ID: 29981404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Graphene Oxide-Based Anticancer Drug Combination Functionalized with Folic Acid as Nanocarrier for Targeted Delivery of Methotrexate.
    Yanikoglu R; Karakas CY; Ciftci F; Insel MA; Karavelioglu Z; Varol R; Yilmaz A; Cakir R; Uvet H; Ustundag CB
    Pharmaceutics; 2024 Jun; 16(6):. PubMed ID: 38931957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.